Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.800
0.00 (0.00%)
Dec 4, 2025, 9:30 AM EST
Silence Therapeutics Employees
Silence Therapeutics had 116 employees as of December 31, 2024. The number of employees increased by 7 or 6.42% compared to the previous year.
Employees
116
Change (1Y)
7
Growth (1Y)
6.42%
Revenue / Employee
$222,672
Profits / Employee
-$556,379
Market Cap
328.75M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Zomedica | 152 |
| Nuo Therapeutics | 9 |
Silence Therapeutics News
- 18 days ago - Silence Therapeutics: Divesiran Targets High-Burden PV - Seeking Alpha
- 24 days ago - Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference - Business Wire
- 4 weeks ago - Silence Therapeutics plc Non-GAAP EPS of -$0.15, revenue of $0.16M - Seeking Alpha
- 4 weeks ago - Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 6 weeks ago - Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV) - Business Wire
- 2 months ago - Silence Therapeutics (SLN) Receives Reiterated Buy Rating from HC Wainwright | SLN Stock News - GuruFocus
- 3 months ago - Silence Therapeutics Plc (SLN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 3 months ago - Silence Therapeutics to Participate in September Investor Conferences - Business Wire